Fast Market Research

"Portugal in Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" Published

New Medical Devices market report from Global Markets Direct: "Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018"

 
Repost This

Boston, MA -- (SBWIRE) -- 01/28/2013 -- Global Markets Direct's new report, "Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" provides key market data on the Portugal In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

View Full Report Details and Table of Contents

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the twelve market categories.
- Global corporate-level profiles of key companies operating within the Portugal In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc. and others.

Reasons to Get this Report

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Portugal In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Alere Inc., Sysmex Corporation, Danaher Corporation, DiaSorin S.p.A, Qiagen N.V., Diagnostica Stago, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Horiba, Ltd., Gen-Probe Incorporated, Immucor, Inc., Life Technologies Corporation, Cellestis Limited, Phadia AB

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Turkey In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
- Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018